Autopsy report · NCT00875160

A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101

“Subject Recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Amicus Therapeutics

Sponsor type

Industry

Conditions

Type 1 Gaucher Disease

Interventions

AT2101

Participants

1

Sites

2

Countries

United Kingdom, United States

Trials that died the same way

• CytID Analysis of Oral Lesions
  “low subject recruitment” (86% match in meaning)
• Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction
  “Lack of Subject Recruitment” (82% match in meaning)
• Home Program Education for Patients With Low Back Pain
  “Not recruiting subjects currently” (80% match in meaning)
• Checkpoint Blockade in COVID-19 Pandemic
  “Recruitment issues” (78% match in meaning)
• Measles Vaccine in HCW
  “Failure of subject recruitment” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.